NM_004924.6:c.2679C>T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_004924.6(ACTN4):c.2679C>T(p.Pro893Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000232 in 1,612,754 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.00037   (  0   hom.,  cov: 31) 
 Exomes 𝑓:  0.00022   (  2   hom.  ) 
Consequence
 ACTN4
NM_004924.6 synonymous
NM_004924.6 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -1.75  
Publications
1 publications found 
Genes affected
 ACTN4  (HGNC:166):  (actinin alpha 4)  Alpha actinins belong to the spectrin gene superfamily which represents a diverse group of cytoskeletal proteins, including the alpha and beta spectrins and dystrophins.  Alpha actinin is an actin-binding protein with multiple roles in different cell types.  In nonmuscle cells, the cytoskeletal isoform is found along microfilament bundles and adherens-type junctions, where it is involved in binding actin to the membrane.  In contrast, skeletal, cardiac, and smooth muscle isoforms are localized to the Z-disc and analogous dense bodies, where they help anchor the myofibrillar actin filaments.  This gene encodes a nonmuscle, alpha actinin isoform which is concentrated in the cytoplasm, and thought to be involved in metastatic processes.  Mutations in this gene have been associated with focal and segmental glomerulosclerosis. [provided by RefSeq, Jul 2008] 
ACTN4 Gene-Disease associations (from GenCC):
- focal segmental glomerulosclerosis 1Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65). 
BP6
Variant 19-38729375-C-T is Benign according to our data. Variant chr19-38729375-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 585364.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000375 (57/152186) while in subpopulation EAS AF = 0.00639 (33/5168). AF 95% confidence interval is 0.00467. There are 0 homozygotes in GnomAd4. There are 33 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check. 
BS2
High AC in GnomAd4 at 57 AD gene. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| ACTN4 | NM_004924.6 | c.2679C>T | p.Pro893Pro | synonymous_variant | Exon 21 of 21 | ENST00000252699.7 | NP_004915.2 | 
Ensembl
Frequencies
GnomAD3 genomes  0.000375  AC: 57AN: 152068Hom.:  0  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
57
AN: 
152068
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000610  AC: 152AN: 249116 AF XY:  0.000576   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
152
AN: 
249116
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.000217  AC: 317AN: 1460568Hom.:  2  Cov.: 36 AF XY:  0.000211  AC XY: 153AN XY: 726598 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
317
AN: 
1460568
Hom.: 
Cov.: 
36
 AF XY: 
AC XY: 
153
AN XY: 
726598
show subpopulations 
African (AFR) 
 AF: 
AC: 
1
AN: 
33480
American (AMR) 
 AF: 
AC: 
11
AN: 
44712
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26118
East Asian (EAS) 
 AF: 
AC: 
232
AN: 
39700
South Asian (SAS) 
 AF: 
AC: 
7
AN: 
86248
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
52190
Middle Eastern (MID) 
 AF: 
AC: 
6
AN: 
5764
European-Non Finnish (NFE) 
 AF: 
AC: 
41
AN: 
1111980
Other (OTH) 
 AF: 
AC: 
19
AN: 
60376
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.490 
Heterozygous variant carriers
 0 
 24 
 48 
 72 
 96 
 120 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 10 
 20 
 30 
 40 
 50 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.000375  AC: 57AN: 152186Hom.:  0  Cov.: 31 AF XY:  0.000443  AC XY: 33AN XY: 74424 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
57
AN: 
152186
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
33
AN XY: 
74424
show subpopulations 
African (AFR) 
 AF: 
AC: 
1
AN: 
41516
American (AMR) 
 AF: 
AC: 
17
AN: 
15294
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
33
AN: 
5168
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4818
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10610
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
4
AN: 
67996
Other (OTH) 
 AF: 
AC: 
2
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.509 
Heterozygous variant carriers
 0 
 3 
 6 
 9 
 12 
 15 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2
AN: 
3478
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Benign/Likely benign 
Submissions summary: Benign:6 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:3 
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mar 27, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Focal segmental glomerulosclerosis 1    Benign:2 
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jul 26, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Kidney disorder    Benign:1 
Jun 24, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.